HomeALLO • NASDAQ
add
Allogene Therapeutics Inc
Previous close
$2.11
Day range
$2.09 - $2.23
Year range
$1.99 - $5.78
Market cap
463.38M USD
Avg Volume
2.30M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.33M | -4.15% |
Net income | -66.29M | -6.43% |
Net profit margin | — | — |
Earnings per share | -0.27 | 28.22% |
EBITDA | -57.84M | 2.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 291.56M | -37.37% |
Total assets | 589.12M | -17.30% |
Total liabilities | 125.37M | -2.98% |
Total equity | 463.75M | — |
Shares outstanding | 209.67M | — |
Price to book | 0.95 | — |
Return on assets | -24.69% | — |
Return on capital | -26.19% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -66.29M | -6.43% |
Cash from operations | -44.12M | 20.56% |
Cash from investing | -75.99M | -121.76% |
Cash from financing | 679.00K | -84.15% |
Net change in cash | -119.43M | -39.66% |
Free cash flow | -40.70M | 20.06% |
About
Founded
2017
Headquarters
Website
Employees
232
